Clinical implications of age and excellent response to therapy in patients with high‐risk differentiated thyroid carcinoma-Reference-Cited by-同舟云学术

Clinical implications of age and excellent response to therapy in patients with high‐risk differentiated thyroid carcinoma

Published:2021-07-12 Issue:6 Volume:95 Page:882-890
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clinical Endocrinology

Author:

Jin Meihua¹^ORCID,Ahn Jonghwa¹^ORCID,Lee Yu‐Mi²^ORCID,Sung Tae‐Yon²,Song Dong Eun³,Kim Tae Yong¹,Chung Ki‐Wook²,Ryu Jin‐Sook⁴,Kim Won Bae¹^ORCID,Shong Young Kee¹,Jeon Min Ji¹^ORCID,Kim Won Gu¹^ORCID

Affiliation:

1. Department of Internal Medicine, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

2. Department of Surgery, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

3. Department of Pathology, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

4. Department of Nuclear Medicine, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

Funder

Asan Institute for Life Sciences, Asan Medical Center

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14543

Reference33 articles.

1. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

2. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

3. Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System

4. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy

5. Outcomes of Patients with Differentiated Thyroid Cancer Risk-Stratified According to the American Thyroid Association and Latin American Thyroid Society Risk of Recurrence Classification Systems

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basal or stimulated thyroglobulin in evaluating response to treatment in papillary thyroid carcinoma? A retrospective cohort study;Hormones;2023-11-28

2. Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients;The Journal of Clinical Endocrinology & Metabolism;2023-10-07

3. Effect of Hashimoto’s Thyroiditis on Efficacy of <sup>131</sup>I Ablation Therapy in Intermediate- and High-Risk of Thyroid Papillary Carcinoma;Journal of Biosciences and Medicines;2023

4. Preoperative voice analysis and survival outcomes in papillary thyroid cancer with recurrent laryngeal nerve invasion;Frontiers in Endocrinology;2022-10-27